Table 1.
Serotype | Pre-Vaccination IgG < 1.3 µg/mL |
Pre-Vaccination IgG ≥ 1.3 µg/mL |
p Value | |||||
---|---|---|---|---|---|---|---|---|
Number | Seroconversion Rate | GMFR | Number | Seroconversion Rate | GMFR | P1 a | P2 b | |
1 | 317 | 92.74 | 11.09 | 210 | 88.10 | 6.59 | NS | <0.05 |
2 | 271 | 95.57 | 13.18 | 313 | 87.86 | 7.30 | <0.05 | <0.05 |
3 | 484 | 68.18 | 3.77 | 80 | 26.25 | 1.44 | <0.05 | <0.05 |
4 | 435 | 85.52 | 7.09 | 82 | 71.95 | 3.58 | <0.05 | <0.05 |
5 | 412 | 87.38 | 7.39 | 172 | 73.84 | 4.26 | <0.05 | <0.05 |
6B | 212 | 79.72 | 5.17 | 351 | 72.36 | 3.72 | NS | <0.05 |
7 | 280 | 92.86 | 11.44 | 283 | 86.93 | 6.21 | <0.05 | <0.05 |
8 | 118 | 94.07 | 10.70 | 439 | 82.69 | 5.15 | <0.05 | <0.05 |
9N | 226 | 95.58 | 12.44 | 358 | 89.39 | 7.02 | <0.05 | <0.05 |
9V | 193 | 87.56 | 5.91 | 383 | 81.46 | 4.23 | NS | <0.05 |
10A | 195 | 84.62 | 7.24 | 337 | 90.21 | 7.61 | NS | NS |
11A | 168 | 88.69 | 6.20 | 385 | 74.55 | 3.58 | <0.05 | <0.05 |
12F | 391 | 78.01 | 4.48 | 186 | 58.06 | 2.49 | <0.05 | <0.05 |
14 | 152 | 91.45 | 11.19 | 416 | 70.19 | 4.44 | <0.05 | <0.05 |
15B | 85 | 95.29 | 9.35 | 484 | 83.88 | 5.11 | <0.05 | <0.05 |
17F | 283 | 90.81 | 9.02 | 263 | 86.69 | 5.40 | NS | <0.05 |
18C | 213 | 92.49 | 8.34 | 334 | 82.63 | 4.43 | <0.05 | <0.05 |
19A | 274 | 79.56 | 6.20 | 294 | 81.29 | 5.60 | NS | NS |
19F | 128 | 88.28 | 4.96 | 433 | 72.98 | 3.62 | <0.05 | <0.05 |
20A | 82 | 74.39 | 3.87 | 478 | 63.60 | 2.78 | NS | <0.05 |
22F | 334 | 87.72 | 7.87 | 135 | 71.11 | 4.35 | <0.05 | <0.05 |
23F | 358 | 85.75 | 6.84 | 209 | 67.94 | 3.17 | <0.05 | <0.05 |
33F | 93 | 93.55 | 13.50 | 466 | 92.06 | 7.42 | NS | <0.05 |
a: Seroconversion rates of pre-vaccination IgG < 1.3 µg/mL vs. ≥ 1.3 µg/mL; b: GMFRs of pre-vaccination IgG < 1.3 µg/mL vs. ≥ 1.3 µg/mL.